Satellos Bioscience Statistics

NASDAQ: MSLEHealthcareBiotechnologyUSD

7.63+0.09 (+1.19%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Satellos Bioscience by the numbers

Satellos Bioscience has a market capitalization of $161.9 million based on 21.22M shares outstanding. With trailing EPS of $-1.94, Satellos Bioscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.6% below its 50-day average and 9.7% below its 200-day average.

Average daily trading volume is 51.35K shares, or about $391,801 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MSLE valuation vs. peer median

MSLE compared with the median of 8 peer companies
Metric	MSLE	Peer median	Difference
Market cap	$161.88M	$156.43M	+3%
Avg. volume	51.35K	328.67K	-84%

Peer median across 8 companies: NBP, NKTX, MENS, CUE, ALXO, NERV, CHRS, KRRO.

Valuation

Market cap: $161.88M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-1.94
Shares outstanding: 21.22M

Price and trading

Previous close: 7.54
Open: 7.54
Day range: 7.54 – 8.35
52-week range: 5.30 – 13.40
52-week change: +5.44%
50-day moving average: 9.38
200-day moving average: 8.45
Beta: —
Volume: 47.53K
Average volume: 51.35K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 12, 2026

Additional statistics

Market Cap: 161.88M
Forward Pe: -2.78
Eps: -1.94
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 13.40
Week52 Low: 5.30
Avg Volume: 51,350.00
Shares Outstanding: 21.22M
Ma50: 9.38
Ma200: 8.45
Earnings Date: Nov 12, 2026
Pct From52w High: -43.04%
Pct From52w Low: 43.85%